COST given budget boost for FP7

COST, the European Cooperation in Science and Technology, will continue to be managed by the European Science Foundation (ESF) under the Seventh Framework Programme (FP7). The European Commission and ESF signed a contract to this effect at the end of July.

Under the Sixth Framework Programme (FP6), EU support for COST amounted to €80 million, a figure which is set to rise to €210 million under FP7. An additional €40 million could be added to the pot if a mid-term evaluation in 2010 is successful.

"The contract and the increase in funding is indeed a strong vote of confidence towards the ESF-COST cooperation," said Dr Martin Grabert, Director of the COST Office. "With this contract, we can truly capitalise on previous successes. We will not rest on our laurels, however, and continue to focus on cross-disciplinary initiatives and strengthening the synergy between the various research actors in Europe."

The bigger budget will allow COST to expand its activities and boost support for both the scientific and technical committees and the COST Actions (networks of researchers).

The contract sets out a series of work packages which reflect the increase in funding through new and expanded activities, the development of new ideas for interdisciplinary science initiatives and a greater exploitation of the European 'Near Neighbours' policy. There is also a stronger focus on outreach and communications.

"The negotiation of this contract and the transition between FP6 and FP7 were two challenging processes," commented David Weber, the ESF's Director of Administration and Finance, noting that the ESF's commitment to COST, coupled with its experience of managing such a complex operation, had been key to the successful completion of the agreement.

"I very much welcome the positive conclusion of the negotiations for the signature of the EC-ESF contract for COST," added Professor Francesco Fedi, President of the COST Committee of Senior Officials. "COST has always been a unique instrument with a strong role to play towards the development of the ERA. Typical COST features such as its flexibility and bottom-up approach make it a perfect platform for innovative ideas on the frontiers of science."

A recent independent review of the Commission-ESF COST contract for FP6 noted the high levels of satisfaction among users of COST and concluded that the switchover from the COST Action managed by the European to the COST Office run by the ESF had been largely successful.

Established in 1971, COST is now used by researchers in 35 European countries to cooperate in common research projects supported by national funds.

For more information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...